• 제목/요약/키워드: Cancer Pain Management

검색결과 266건 처리시간 0.024초

호스피스.완화의료 환자에게 적용한 방사선 치료의 부작용과 대처법 (The Adverse Effects of Radiotherapy and Its Management in the Hospice and Palliative Care Patients)

  • 이순신;박영진;한성호;박주성
    • Journal of Hospice and Palliative Care
    • /
    • 제14권2호
    • /
    • pp.61-70
    • /
    • 2011
  • 최근 암 발생의 증가와 그에 따른 방사선 치료의 증가로 방사선 치료의 부작용은 암환자에서 치료 후 고려되어야 할 중요한 부작용 중 하나이다. 방사선 치료의 후기 부작용의 위험성이 있는 장기 암 생존자가 재발하여 호스피스 완화의료를 받게 되거나 말기암환자가 완화 목적의 방사선 치료를 받게 되는 경우 방사선 치료 부작용에 대한 이해와 지식이 이들 환자에 대한 의학적 진단 및 관리와 조정에 도움이 될 수 있을 것이다. 암환자의 생존율 향상과 암 치료 부작용의 감소를 위해 암 치료에 대한 많은 연구와 발전이 이루어지고 있지만, 임상에서 방사선 치료를 포함한 암 치료 부작용의 관리에 대한 관심은 상대적으로 적은 편이고 이에 대한 치료의 발전도 더디고 부족하다. 환자의 고통을 덜어주고 삶의 질을 유지, 향상시킬 수 있는 사후 관리를 위해 치료의 부작용과 관리에 대해 충분히 숙지할 필요가 있고, 향후 보완 통합적 접근으로 적극적인 연구와 관심이 필요할 것으로 생각된다.

Gamma Knife Radiosurgery for Cancer Metastasized to the Ocular Choroid

  • Cho, Kyung Rae;Lee, Kyung Min;Han, Gyule;Kang, Se Woong;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제61권1호
    • /
    • pp.60-65
    • /
    • 2018
  • Objective : Choroidal metastases (CMs) are the most common intraocular tumor. Management is mainly radiation therapy with goals of pain control and visual improvement. However, many radiation-related complications are reported. Since gamma knife radiosurgery (GKS) for CM was first reported in 1995, few cases have been reported. We report 7 cases of CMs treated with GKS. Methods : From April 2011 to November 2014, 7 patients with CM underwent GKS. Their median age at treatment was 64 years (range, 51-71 years). Four males and three females were treated. Lung cancer was the most common primary pathology, followed by renal cell carcinoma and stomach cancer. Four patients had multiple cerebral lesions and were treated simultaneously for choroidal lesions. The median marginal dose of 20 Gy (range, 15-25 Gy) was administered at the 50% isodose line. Results : Median follow-up period after GKS was 8 months (range, 2-38.3 months). Four patients expired due to underlying malignancy progression. Except for two patients who were not followed with magnetic resonance image after GKS, all patients showed size reduction in the treated lesions, but a new choroidal lesion appeared in one patient and one recurred. Six of seven patients reported subjectively improved visual symptoms. Visual acuity improved in 2 patients, and 2 were stable upon objective examination. One patient showed no improvement in visual acuity, but ocular pain was relieved; another patient showed improved vision and tumor remission, but visual deterioration recurred. Conclusion : GKS was shown to be safe and effective and should be considered for CM treatment.

중·고령 초기 유방암 생존자를 돌보는 가족의 경험 (Family Members' Caregiving Experience for Middle-aged and Elderly Breast Cancer Survivors at Early Stages)

  • 박소영;박향경;구향나;백정연;노은정
    • 한국노년학
    • /
    • 제40권1호
    • /
    • pp.111-130
    • /
    • 2020
  • 본 연구는 중·고령 초기 유방암 생존자를 위한 가족들의 돌봄 경험에 대해 이해하고자 한 질적 연구이다. 총 4명의 유방암 생존자 가족들을 대상으로 초점집단면접(FGI)을 실시하였고 추가로 1명의 가족에 대해 개별심층면접을 실시하였다. 초점집단면접과 개별심층면접 내용을 주제 분석한 결과, 다음 4가지 주제가 나타났다: 첫째, 살얼음 위를 걷는 듯한 일상의 감정들 (치료시기마다 서로 뒤얽히는 감정들, 생존자의 고통을 지켜볼 수밖에 없는 안타까움, 암 재발과 죽음에 대한 두려움, 관계 변화에 대한 걱정, 딸로서 겪는 다양한 감정), 둘째, 생활의 중심이 된 돌봄 (낯설고 서툴렀던 돌봄, 내 생활을 잃어감), 셋째, 회복의 시작, 생존자와 가족이 느끼는 온도 차이 (생존자가 느끼는 심연의 고통을 헤아리지 못함, 생존자가 아직 환자라는 사실을 잊고 소홀히 대함), 넷째, 앞으로 나아가기 (나아질 것이라는 희망, 지치지 않기 위한 나를 위한 돌봄). 본 연구 결과를 토대로 유방암 생존자 가족의 심리사회적 욕구를 반영하고 돌봄 과정에서 가족 지지를 지원하기 위한 사회복지서비스 및 정책 방안에 대해 제언하였다.

양성질환의 방사선치료 (Radiotherapy for Benign Diseases)

  • 최상규
    • 한국방사선학회논문지
    • /
    • 제10권8호
    • /
    • pp.611-618
    • /
    • 2016
  • 암의 3대 표준요법중의 하나인 방사선치료는 전통적으로 악성 종양인 암의 근치적 혹은 고식적 치료외에도 일부 증식성이거나 염증성을 보이는 양성 질환에서도 그동안 꾸준하게 시행되어왔다. 양성질환의 경우 악성 종양과는 달리 약물요법이나 보존요법 또는 수술로 만족할 만한 치료성적을 낼 수 있으나 이런 치료들이 실패하거나 불가능한 경우 저선량의 방사선치료를 추가하거나 병용하여 시행하는 경우 인체에 큰 문제없이 안전하고 용이하게 통증완화나 재발율을 의미있게 낮출 수 있다. 최근 방사선치료기법의 발달로 정상조직을 최대한 보존하면서 원하는 부위로의 집중적 치료가 가능해지면서 특히 노인에게서 유용한 대안이 될 수 있을 것으로 생각된다.

Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study

  • Unal, Olcun Umit;Yilmaz, Ahmet Ugur;Yavuzsen, Tugba;Akman, Tulay;Ellidokuz, Hulya
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권15호
    • /
    • pp.6165-6169
    • /
    • 2014
  • Background: The advantage of intra-peritoneal (IP) chemotherapy (CT) in the initial management of ovarian cancer after cytoreductive surgery is well known. The feasibility and toxicity of a treatment regimen with an IP + intravenous CT (IPIVCT) for optimally debulked stage III ovarian cancer were here evaluated retrospectively. Materials and Methods: A total of 30 patients were treated in our institution between October 2006 and February 2011. Patients received IV paclitaxel $175mg/m^2$ over 3 hours followed by IP cisplatin $75mg/m^2$ on day 1; they also received IP paclitaxel $60mg/m^2$ on day 8. They were also scheduled to receive 6 courses of CT every 21 days. Results: The median age of the patients was 55 years (35-77), and the majority had papillary serous ovarian cancer (63.3%). The patients completed a total of 146 cycles of IPIVCT. Twenty-eight were able to receive at least three cycles of IPIVCT and 18 (60%) completed the scheduled 6 cycles. Two patients discontinued the IPIVCT because of toxicity of chemotherapy agents and 6 had to stop treatment due to intolerable abdominal pain during IP drug administration, obstruction and impaired access. Grade 3/4 toxicities included neutropenia (6 patients; 20%), anemia (2 patients; 6.7%) and nausea-vomiting (2 patients; 6.7%). Doses were delayed in 12 cycles (8%) for neutropenia (n=6), thrombocytopenia (n=3) and elevated creatinine (n=3). Drug doses were not reduced. The median duration of progression-free survival (PFS) was 47.7 months (95%CI, 38.98-56.44) and overall survival (OS) was 51.7 months (95%CI, 44.13-59.29). Two and five-year overall survival rates were 75.6 % and 64.8%, respectively. Conclusions: IPIVCT is feasible and well-tolerated in this setting. Its clinically proven advantages should be taken into consideration and more efforts should be made to administer IPIVCT to suitable patients.

방사선 치료 중인 암환자의 정신병리, 자아존중감 및 삶의 질 (Psychopathology, Self Esteem and Quality of Life in Cancer Patients with Radiotherapy)

  • 정찬영;양종철;신일선;최영;윤진상;이무석;이형영;나병식
    • 정신신체의학
    • /
    • 제10권2호
    • /
    • pp.92-100
    • /
    • 2002
  • 목적: 의학의 발달에 따라 암환자의 생존율이 높아졌으며, 이에 따라 암환자의 심리적 이해와 삶의 질의 향상이 중요시되고 있다. 본 연구의 목적은 암환자의 사회인구학적 변인과 임상적 특성에 따라 정신병리, 자아존중감 및 삶의 질 등이 어떤 양상을 보이는 지 조사하고 동시에 이틀 간의 상호 연관성에 대해 알아보고자 함에 있다. 방법: 전남대학교병원 치료방사선과에 정규적으로 방사선치료를 받고있는 암환자 41 명과 정상 대조 군 20명을 대상으로 하였다. 환자들의 사회인구학적 자료 및 임상적 특성을 평가하였고, 정신병리는 symptom checklist-90-revised, 자아존중감은 Rosenberg의 self-esteem scale, 삶의 질은 World Health Organization Quality of Life Assessment Instrument를 통해 두 군을 비교 분석한 후, 변인들간의 상관을 조사하였다. 결과: 1) 암환자 군은 정상대조 군에 비해 신체화, 강박, 우울, 불안, 적대감, 공포, 정신중적 경향 등이 더 높았는데, 특히 신체화와 불안, 정신중이 유의하게 높았다. 2) 자아 존중감과 삶의 질은 암환자 군이 정상대조 군보다 유의하게 낮았다. 3) 사회인구학적 변인에 따른 정신병리, 자아존중감, 삶의 질의 비교에서는 유의한 차이가 없었다. 임상적 특정 중에서는 체중감량이 심할수록 신체화가 높았으며, 통증이 있는 경우에 신체화가 높고 삶의 질이 낮게 나타났다. 4) 불안이 높을수록 자아존중감이 낮았고, 신체화와 불안이 높고 자아존중감이 낮을수록 삶의 질이 낮게 나타났다. 결론: 암환자는 여러 정신증상이 있었고, 자아존중감과 삶의 질이 낮았다. 특히 암환자의 삶의 질에는 신체화 및 불안 등의 정신중상, 자아존중감, 통증 등이 중요한 것으로 드러났다. 따라서 암환자의 치료와 삶의 질의 개선을 위해서는 정신증상의 치료와 자아존중감의 증진, 통증 관리 등이 필요할 것으로 생각된다.

  • PDF

국내 암환자를 대상으로 한 간호중재 연구현황 및 분석 (The analysis of Trends and Contents of Nursing Intervention Research for Cancer Patients in Korea)

  • 홍명선;염영희;김근면
    • 종양간호연구
    • /
    • 제12권4호
    • /
    • pp.247-256
    • /
    • 2012
  • Purpose: In this study, the articles which developed and applied nursing interventions for patients with cancer were reviewed and analyzed. Methods: The analysis was performed in light of 171 pieces of literature on nursing interventions for patients with cancer published between 1991 and 2010. Results: Approximately half of the studies have been published between 2006 and 2010. The quasi-experimental designs using nonequivalent control group and no-synchronized design were the most common form of research design among the 71 papers constituting 41.52% of the total. The most commonly used nursing intervention was education (25.2%), followed by massage (20.4%) and exercise (11.5%). The most common outcome variable was anxiety (11.8%), followed by pain (8.0%) and nausea and vomiting (7.3%). Conclusion: The results of this study can provide useful information for the development of nursing interventions in specialized areas. Systematic literature review or meta-analysis is needed in this area.

항암제 투여 후 발생한 수족비증(手足痺症) 환자 치험례 (Traditional Korean Medical Treatment for Chemotherapy-induced Peripheral Neuropathy - a Case Report)

  • 유승연;정종수;박재우;윤성우
    • 대한암한의학회지
    • /
    • 제12권1호
    • /
    • pp.83-89
    • /
    • 2007
  • Chemotherapy has many known side effects. Neuropathy is a common side effect when using cisplatin. The clinical course varies and depends on the agents used and their cumulative dose. Although symptoms can resolve completely, in most patients chemotherapy-induced peripheral neuropathy is either only partially reversible or completely irreversible. Current management for chemotherapy-induced peripheral neuropathy is symptomatic relief using membrane stabilizing medications and antidepressants. Dysaesthesia and pain involving the feet and hands are described in traditional korean medicine. In traditional korean medicine, the pathogenesis is related to the inability to direct Qi and Blood to the extremities, and is associated with Qi, Blood, Yang and Kidney deficiencies. We report a case of a 52 years old female patient treated with acupuncture and bleeding treatment for the goal of improving the symptoms of chemotherapy induced peripheral neuropathy. Further study and other medical method will be needed in order to improve the effect and determine the long-term effect of traditional korean medicine in treating Chemotherapy-induced Peripheral Neuropathy.

  • PDF

식도 천공의 보존적 치료 - 임상적 고찰 14례 (Conservative Management of Esophageal Perforation; Clinical analysis of 14 cases)

  • 배병우;이형렬;김종원
    • Journal of Chest Surgery
    • /
    • 제26권8호
    • /
    • pp.633-637
    • /
    • 1993
  • Twenty-five patients with perforation of esophagus were managed at Pusan National University Hospital, from 1981 to 1993. The hospital course of 14 of these patients was evaluated with a special emphasis on the cause and location of perforation, clinical presentation, time elapsed from perforation to treatment, method of treatment, and outcome. Patients with anastomotic leak and cancer were excluded.The perforation was iatrogenic in 7 patients, spontaneous in 5, ingestion of foreign body in 1, and traumatic in 1. There were 7 cervical perforations, 2 upper thoracic perforations, and 5 lower thoracic perforations. Chest pain, fever, and dyspnea were frequent symptoms. Esophagography was most diagnostic [11 patients] but thoracentesis was of little diagnostic aid.Antibiotics were administered intravenously to all patients:hyperalimentation was accomplished intravenously in 11, and nasogastric suction was used in all cases. No patient required any surgical procedure, minor or major.

  • PDF

단일 상급종합병원에서 마약성 진통제의 최근 13년간 사용 경향 조사 (Trends in the Consumption of Opioid Analgesics in a Tertiary Care Hospital from 2000 to 2012)

  • 조윤숙;이주연;김향숙;권경희
    • 약학회지
    • /
    • 제58권4호
    • /
    • pp.268-276
    • /
    • 2014
  • Background: World Health Organization considers opioid analgesic use as an important measure in the treatment of pain relief. However, there are limited data about the pattern of opioid analgesic use in tertiary care hospitals in Korea. The aim of this study was to describe the trends in the prescribed amount of the opioid for 13 years from 2000 to 2012 in a single tertiary care hospital. Methods: The data from the prescribed amount of opioid use in patients aged over 18 years were retrieved from medical charts and longitudinal pharmacy records of Seoul National University Hospital. Yearly prescribed amount of opioids were calculated using defined daily dose adjusted by hospital stay (DDD/1000${\bullet}$HS). Results: Over the 13 years of the study period, overall use of opioid has increased by 64.1%. Although, the opioid use by hospitalized patients comprised 98%~99% of total amount of opioid use, the proportions of opioid use by outpatient and by cancer patient increased from 1.1% to 2.2% and from 60.5% to 69.3%, respectively. The use of non-injectable opioids has increased by 47% and that of injectables has increased by 70%. While the amount of codeine and morphine use has decreased, the use of both transdermal and injection formulation of fentanyl has increased dramatically. Also, the use of oxycodone has increased, especially in outpatient setting. Conclusion: This longitudinal study showed that opioid analgesic use in tertiary hospital, especially in outpatient is continuously increasing. Improvement in pain management in tertiary care hospital can be cautiously inferred based on this results.